Filing Details

SCHEDULE 13G

(Rule 13d-102)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1 (b),
(c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 (b)
(Amendment No. 1)*

(Name of Issuer)

(Title of Class of Securities)

(CUSIP Number)

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

*The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

(1) This Schedule 13G is filed by Jackson Square Ventures I, L.P. (JSVI), Jackson Square Associates I, L.P. (JSA), Jackson Square Ventures, LLC (JSV and, together with JSVI and JSA, the JS Entities), Sigma Partners 7, L.P. (SP 7), Sigma Associates 7, L.P. (SA 7), Sigma Investors 7, L.P. (SI 7), Sigma Management 7, L.L.C., (SM 7 and, together with SP 7, SA 7 and SI 7, the Sigma 7 Entities), Sigma Partners 8, L.P. (SP 8), Sigma Associates 8, L.P. (SA 8) and Sigma Investors 8, L.P. (SI 8), Sigma Management 8, L.L.C. (SM 8 and, together with SP 8, SA 8 and SI 8, the Sigma 8 Entities) (collectively with the JS Entities and the Sigma 7 Entities, the Sigma Entities).  The Sigma Entities expressly disclaim status as a group for purposes of this Schedule 13G.

(2) The shares are held by SP 7.  SM 7 is the sole general partner of SP 7 and owns no shares of the issuer directly.   SM 7 holds voting and dispositive power over the shares held by SP 7. The Sigma 7 Entities expressly disclaim beneficial ownership of the shares reported herein as beneficially owned by the JS Entities and the Sigma 8 Entities, and the inclusion of such shares in this report shall not be construed as an admission that the Sigma 7 Entities beneficially own such securities.

(3) This percentage is calculated based upon 179,455,116 shares of the Common Stock outstanding as of November 30, 2019, as set forth in the Issuers most recent Form 10-Q filed with the Securities and Exchange Commission on December 6, 2019.

2

(1) This Schedule 13G is filed by Jackson Square Ventures I, L.P. (JSVI), Jackson Square Associates I, L.P. (JSA), Jackson Square Ventures, LLC (JSV and, together with JSVI and JSA, the JS Entities), Sigma Partners 7, L.P. (SP 7), Sigma Associates 7, L.P. (SA 7), Sigma Investors 7, L.P. (SI 7), Sigma Management 7, L.L.C., (SM 7 and, together with SP 7, SA 7 and SI 7, the Sigma 7 Entities), Sigma Partners 8, L.P. (SP 8), Sigma Associates 8, L.P. (SA 8) and Sigma Investors 8, L.P. (SI 8), Sigma Management 8, L.L.C. (SM 8 and, together with SP 8, SA 8 and SI 8, the Sigma 8 Entities) (collectively with the JS Entities and the Sigma 7 Entities, the Sigma Entities).  The Sigma Entities expressly disclaim status as a group for purposes of this Schedule 13G.

(2) The shares are held by SA 7. SM 7 is the sole general partner of SA 7 and owns no shares of the issuer directly.   SM 7 holds voting and dispositive power over the shares held by SA 7. The Sigma 7 Entities expressly disclaim beneficial ownership of the shares reported herein as beneficially owned by the JS Entities and the Sigma 8 Entities, and the inclusion of such shares in this report shall not be construed as an admission that the Sigma 7 Entities beneficially own such securities.

(3) This percentage is calculated based upon 179,455,116 shares of the Common Stock outstanding as of November 30, 2019, as set forth in the Issuers most recent Form 10-Q filed with the Securities and Exchange Commission on December 6, 2019.

3

(1) This Schedule 13G is filed by Jackson Square Ventures I, L.P. (JSVI), Jackson Square Associates I, L.P. (JSA), Jackson Square Ventures, LLC (JSV and, together with JSVI and JSA, the JS Entities), Sigma Partners 7, L.P. (SP 7), Sigma Associates 7, L.P. (SA 7), Sigma Investors 7, L.P. (SI 7), Sigma Management 7, L.L.C., (SM 7 and, together with SP 7, SA 7 and SI 7, the Sigma 7 Entities), Sigma Partners 8, L.P. (SP 8), Sigma Associates 8, L.P. (SA 8) and Sigma Investors 8, L.P. (SI 8), Sigma Management 8, L.L.C. (SM 8 and, together with SP 8, SA 8 and SI 8, the Sigma 8 Entities) (collectively with the JS Entities and the Sigma 7 Entities, the Sigma Entities).  The Sigma Entities expressly disclaim status as a group for purposes of this Schedule 13G.

(2) The shares are held by SI 7.  SM 7 is the sole general partner of SI 7 and owns no shares of the issuer directly.   SM 7 holds voting and dispositive power over the shares held by SI 7. The Sigma 7 Entities expressly disclaim beneficial ownership of the shares reported herein as beneficially owned by the JS Entities and the Sigma 8 Entities, and the inclusion of such shares in this report shall not be construed as an admission that the Sigma 7 Entities beneficially own such securities.

(3) This percentage is calculated based upon 179,455,116 shares of the Common Stock outstanding as of November 30, 2019, as set forth in the Issuers most recent Form 10-Q filed with the Securities and Exchange Commission on December 6, 2019.

4

(1) This Schedule 13G is filed by Jackson Square Ventures I, L.P. (JSVI), Jackson Square Associates I, L.P. (JSA), Jackson Square Ventures, LLC (JSV and, together with JSVI and JSA, the JS Entities), Sigma Partners 7, L.P. (SP 7), Sigma Associates 7, L.P. (SA 7), Sigma Investors 7, L.P. (SI 7), Sigma Management 7, L.L.C., (SM 7 and, together with SP 7, SA 7 and SI 7, the Sigma 7 Entities), Sigma Partners 8, L.P. (SP 8), Sigma Associates 8, L.P. (SA 8) and Sigma Investors 8, L.P. (SI 8), Sigma Management 8, L.L.C. (SM 8 and, together with SP 8, SA 8 and SI 8, the Sigma 8 Entities) (collectively with the JS Entities and the Sigma 7 Entities, the Sigma Entities).  The Sigma Entities expressly disclaim status as a group for purposes of this Schedule 13G.

(2) Includes: (i) 1,687,973 shares held by SP 7; (ii) 109,352 shares held by SA 7; and (iii) 20,487 shares held by SI 7.  SM 7 is the sole general partner of SP 7, SA 7 and SI 7 and owns no shares of the issuer directly.   SM 7 holds voting and dispositive power over the shares held by SP 7, SA 7 and SI 7. The Sigma 7 Entities expressly disclaim beneficial ownership of the shares reported herein as beneficially owned by the JS Entities and the Sigma 8 Entities, and the inclusion of such shares in this report shall not be construed as an admission that the Sigma 7 Entities beneficially own such securities.

(3) This percentage is calculated based upon 179,455,116 shares of the Common Stock outstanding as of November 30, 2019, as set forth in the Issuers most recent Form 10-Q filed with the Securities and Exchange Commission on December 6, 2019.

5

(1) This Schedule 13G is filed by Jackson Square Ventures I, L.P. (JSVI), Jackson Square Associates I, L.P. (JSA), Jackson Square Ventures, LLC (JSV and, together with JSVI and JSA, the JS Entities), Sigma Partners 7, L.P. (SP 7), Sigma Associates 7, L.P. (SA 7), Sigma Investors 7, L.P. (SI 7), Sigma Management 7, L.L.C., (SM 7 and, together with SP 7, SA 7 and SI 7, the Sigma 7 Entities), Sigma Partners 8, L.P. (SP 8), Sigma Associates 8, L.P. (SA 8) and Sigma Investors 8, L.P. (SI 8), Sigma Management 8, L.L.C. (SM 8 and, together with SP 8, SA 8 and SI 8, the Sigma 8 Entities) (collectively with the JS Entities and the Sigma 7 Entities, the Sigma Entities).  The Sigma Entities expressly disclaim status as a group for purposes of this Schedule 13G.

(2) The shares are held by SP 8.  SM 8 is the sole general partner of SP 8 and owns no shares of the issuer directly.   SM 8 holds voting and dispositive power over the shares held by SP 8. The Sigma 8 Entities expressly disclaim beneficial ownership of the shares reported herein as beneficially owned by the JS Entities and the Sigma 7 Entities, and the inclusion of such shares in this report shall not be construed as an admission that the Sigma 8 Entities beneficially own such securities.

(3) This percentage is calculated based upon 179,455,116 shares of the Common Stock outstanding as of November 30, 2019, as set forth in the Issuers most recent Form 10-Q filed with the Securities and Exchange Commission on December 6, 2019.

6

(1) This Schedule 13G is filed by Jackson Square Ventures I, L.P. (JSVI), Jackson Square Associates I, L.P. (JSA), Jackson Square Ventures, LLC (JSV and, together with JSVI and JSA, the JS Entities), Sigma Partners 7, L.P. (SP 7), Sigma Associates 7, L.P. (SA 7), Sigma Investors 7, L.P. (SI 7), Sigma Management 7, L.L.C., (SM 7 and, together with SP 7, SA 7 and SI 7, the Sigma 7 Entities), Sigma Partners 8, L.P. (SP 8), Sigma Associates 8, L.P. (SA 8) and Sigma Investors 8, L.P. (SI 8), Sigma Management 8, L.L.C. (SM 8 and, together with SP 8, SA 8 and SI 8, the Sigma 8 Entities) (collectively with the JS Entities and the Sigma 7 Entities, the Sigma Entities).  The Sigma Entities expressly disclaim status as a group for purposes of this Schedule 13G.

(2) The shares are held by SA 8. SM 8 is the sole general partner of SA 8 and owns no shares of the issuer directly.   SM 8 holds voting and dispositive power over the shares held by SA 8. The Sigma 8 Entities expressly disclaim beneficial ownership of the shares reported herein as beneficially owned by the JS Entities and the Sigma 7 Entities, and the inclusion of such shares in this report shall not be construed as an admission that the Sigma 8 Entities beneficially own such securities.

(3) This percentage is calculated based upon 179,455,116 shares of the Common Stock outstanding as of November 30, 2019, as set forth in the Issuers most recent Form 10-Q filed with the Securities and Exchange Commission on December 6, 2019.

7

(1) This Schedule 13G is filed by Jackson Square Ventures I, L.P. (JSVI), Jackson Square Associates I, L.P. (JSA), Jackson Square Ventures, LLC (JSV and, together with JSVI and JSA, the JS Entities), Sigma Partners 7, L.P. (SP 7), Sigma Associates 7, L.P. (SA 7), Sigma Investors 7, L.P. (SI 7), Sigma Management 7, L.L.C., (SM 7 and, together with SP 7, SA 7 and SI 7, the Sigma 7 Entities), Sigma Partners 8, L.P. (SP 8), Sigma Associates 8, L.P. (SA 8) and Sigma Investors 8, L.P. (SI 8), Sigma Management 8, L.L.C. (SM 8 and, together with SP 8, SA 8 and SI 8, the Sigma 8 Entities) (collectively with the JS Entities and the Sigma 7 Entities, the Sigma Entities).  The Sigma Entities expressly disclaim status as a group for purposes of this Schedule 13G.

(2) The shares are held by SI 8.  SM 8 is the sole general partner of SI 8 and owns no shares of the issuer directly.   SM 8 holds voting and dispositive power over the shares held by SI 8. The Sigma 8 Entities expressly disclaim beneficial ownership of the shares reported herein as beneficially owned by the JS Entities and the Sigma 7 Entities, and the inclusion of such shares in this report shall not be construed as an admission that the Sigma 8 Entities beneficially own such securities.

(3) This percentage is calculated based upon 179,455,116 shares of the Common Stock outstanding as of November 30, 2019, as set forth in the Issuers most recent Form 10-Q filed with the Securities and Exchange Commission on December 6, 2019.

8

(1) This Schedule 13G is filed by Jackson Square Ventures I, L.P. (JSVI), Jackson Square Associates I, L.P. (JSA), Jackson Square Ventures, LLC (JSV and, together with JSVI and JSA, the JS Entities), Sigma Partners 7, L.P. (SP 7), Sigma Associates 7, L.P. (SA 7), Sigma Investors 7, L.P. (SI 7), Sigma Management 7, L.L.C., (SM 7 and, together with SP 7, SA 7 and SI 7, the Sigma 7 Entities), Sigma Partners 8, L.P. (SP 8), Sigma Associates 8, L.P. (SA 8) and Sigma Investors 8, L.P. (SI 8), Sigma Management 8, L.L.C. (SM 8 and, together with SP 8, SA 8 and SI 8, the Sigma 8 Entities) (collectively with the JS Entities and the Sigma 7 Entities, the Sigma Entities).  The Sigma Entities expressly disclaim status as a group for purposes of this Schedule 13G.

(2) Includes: (i) 0 shares held by SP 8; (ii) 0 shares held by SA 8; and (iii) 0 shares held by SI 8.  SM 8 is the sole general partner of SP 8, SA 8 and SI 8 and owns no shares of the issuer directly.   SM 8 holds voting and dispositive power over the shares held SP 8, SA 8 and SI 8. The Sigma 8 Entities expressly disclaim beneficial ownership of the shares reported herein as beneficially owned by the JS Entities and the Sigma 7 Entities, and the inclusion of such shares in this report shall not be construed as an admission that the Sigma 8 Entities beneficially own such securities.

(3) This percentage is calculated based upon 179,455,116 shares of the Common Stock outstanding as of November 30, 2019, as set forth in the Issuers most recent Form 10-Q filed with the Securities and Exchange Commission on December 6, 2019.

9

(1) This Schedule 13G is filed by Jackson Square Ventures I, L.P. (JSVI), Jackson Square Associates I, L.P. (JSA), Jackson Square Ventures, LLC (JSV and, together with JSVI and JSA, the JS Entities), Sigma Partners 7, L.P. (SP 7), Sigma Associates 7, L.P. (SA 7), Sigma Investors 7, L.P. (SI 7), Sigma Management 7, L.L.C., (SM 7 and, together with SP 7, SA 7 and SI 7, the Sigma 7 Entities), Sigma Partners 8, L.P. (SP 8), Sigma Associates 8, L.P. (SA 8) and Sigma Investors 8, L.P. (SI 8), Sigma Management 8, L.L.C. (SM 8 and, together with SP 8, SA 8 and SI 8, the Sigma 8 Entities) (collectively with the JS Entities and the Sigma 7 Entities, the Sigma Entities).  The Sigma Entities expressly disclaim status as a group for purposes of this Schedule 13G.

(2) The shares are held by JSVI. JSV is the sole general partner of JSVI and owns no shares of the issuer directly.   JSV holds voting and dispositive power over the shares held by JSVI. The JS Entities expressly disclaim beneficial ownership of the shares reported herein as beneficially owned by the Sigma 7 Entities  and the Sigma 8 Entities, and the inclusion of such shares in this report shall not be construed as an admission that the JS Entities beneficially own such securities.

(3) This percentage is calculated based upon 179,455,116 shares of the Common Stock outstanding as of November 30, 2019, as set forth in the Issuers most recent Form 10-Q filed with the Securities and Exchange Commission on December 6, 2019.

10

(1) This Schedule 13G is filed by Jackson Square Ventures I, L.P. (JSVI), Jackson Square Associates I, L.P. (JSA), Jackson Square Ventures, LLC (JSV and, together with JSVI and JSA, the JS Entities), Sigma Partners 7, L.P. (SP 7), Sigma Associates 7, L.P. (SA 7), Sigma Investors 7, L.P. (SI 7), Sigma Management 7, L.L.C., (SM 7 and, together with SP 7, SA 7 and SI 7, the Sigma 7 Entities), Sigma Partners 8, L.P. (SP 8), Sigma Associates 8, L.P. (SA 8) and Sigma Investors 8, L.P. (SI 8), Sigma Management 8, L.L.C. (SM 8 and, together with SP 8, SA 8 and SI 8, the Sigma 8 Entities) (collectively with the JS Entities and the Sigma 7 Entities, the Sigma Entities).  The Sigma Entities expressly disclaim status as a group for purposes of this Schedule 13G.

(2) The shares are held by JSA.  JSV is the sole general partner of the JSA and owns no shares of the issuer directly.   JSA holds voting and dispositive power over the shares held by JSA. The JS Entities expressly disclaim beneficial ownership of the shares reported herein as beneficially owned by the Sigma 7 Entities  and the Sigma 8 Entities, and the inclusion of such shares in this report shall not be construed as an admission that the JS Entities beneficially own such securities.

(3) This percentage is calculated based upon 179,455,116 shares of the Common Stock outstanding as of November 30, 2019, as set forth in the Issuers most recent Form 10-Q filed with the Securities and Exchange Commission on December 6, 2019.

11

(1) This Schedule 13G is filed by Jackson Square Ventures I, L.P. (JSVI), Jackson Square Associates I, L.P. (JSA), Jackson Square Ventures, LLC (JSV and, together with JSVI and JSA, the JS Entities), Sigma Partners 7, L.P. (SP 7), Sigma Associates 7, L.P. (SA 7), Sigma Investors 7, L.P. (SI 7), Sigma Management 7, L.L.C., (SM 7 and, together with SP 7, SA 7 and SI 7, the Sigma 7 Entities), Sigma Partners 8, L.P. (SP 8), Sigma Associates 8, L.P. (SA 8) and Sigma Investors 8, L.P. (SI 8), Sigma Management 8, L.L.C. (SM 8 and, together with SP 8, SA 8 and SI 8, the Sigma 8 Entities) (collectively with the JS Entities and the Sigma 7 Entities, the Sigma Entities).  The Sigma Entities expressly disclaim status as a group for purposes of this Schedule 13G.

(2) Includes: (i) 0 shares held by JSVI; and (ii) 0 shares held by JSA.  JSV is the sole general partner of the JSVI and JSA and owns no shares of the issuer directly.   JSV holds voting and dispositive power over the shares held by JSVI and JSA. The JS Entities expressly disclaim beneficial ownership of the shares reported herein as beneficially owned by the Sigma 7 Entities  and the Sigma 8 Entities, and the inclusion of such shares in this report shall not be construed as an admission that the JS Entities beneficially own such securities.

(3) This percentage is calculated based upon 179,455,116 shares of the Common Stock outstanding as of November 30, 2019, as set forth in the Issuers most recent Form 10-Q filed with the Securities and Exchange Commission on December 6, 2019.

12

13

14

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this Statement is true, complete and correct.

15

16

EXHIBIT INDEX

17

Exhibit 99.1

AGREEMENT

Pursuant to Rule 13d-1(k)(l) promulgated pursuant to the Securities Exchange Act of 1934, as amended, the undersigned agree that the attached Schedule 13G is being filed on behalf of each of the undersigned.